She will be responsible for strategically integrating, aligning and driving investor relations, communications and philanthropy functions and activities within Zimmer Biomet.
Mattox has more than two decades of investor relations and communications experiences within the healthcare distribution, pharmaceutical, biotech and medical device industries.
“Keri brings deep expertise and a history of successfully driving effective investor relations, communications and corporate social responsibility programs,” chief financial officer Suky Upadhyay said in a news release. “Her proven track record of integrating investor relations and communications strategies will be critical as we continue to focus on transforming our business.”
Mattox replaces Coleman Lannum who is retiring as senior VP of investor relations and will work with Mattox during the transition period.